Valeria T. Garran

Associate Professor at Pós Graduação - Faculdades Oswaldo Cruz
  • Claim this Profile
Contact Information
us****@****om
(386) 825-5501
Location
BR
Languages
  • English Native or bilingual proficiency
  • Spanish Native or bilingual proficiency

Topline Score

Topline score feature will be out soon.

Bio

Generated by
Topline AI

5.0

/5.0
/ Based on 2 ratings
  • (2)
  • (0)
  • (0)
  • (0)
  • (0)

Filter reviews by:

Cyntia Fioratti

I would recommend Valeria as a professional with strategic and analytical skills. We worked together on an innovative project, in which she was able to conduct a research based on distinct fields of knowledge and converge them into an analysis aligned with the business needs, designing a methodology to better shape the project and creating a strategy to maximize the use of the outcomes of the study. She was also able to conduct a complex analysis, crossing data of several databases, with agility and demonstrating deep knowledge on pricing and reimbursement.

LinkedIn User

Valeria is a professional highly recommend! We met when we studied together Pharmacy and Biochemistry at USP. Since then we developed a close connection and I could observe her positive attitudes such as giving the best of her in every task demanded. She is the best-in-class when it comes to goals achievements, her serious view of the whole business inspires others to work to achieve them together with her. She does not shy away from providing her point of view or coming up with ideas outside the box. Lastly, I surely should mention her knowledge about Regulatory Affairs that contributed to her to become also a Market Access leader when Organon was acquired by MSD.

You need to have a working account to view this content.
You need to have a working account to view this content.

Credentials

  • Writing a Marketing Plan
    LinkedIn
    Aug, 2017
    - Nov, 2024

Experience

    • Brazil
    • Education Administration Programs
    • 100 - 200 Employee
    • Associate Professor
      • Mar 2009 - Present

      Professor of National Legislation for Pharmaceutical Products. http://www.oswaldocruz.br/pos/ Professor of National Legislation for Pharmaceutical Products. http://www.oswaldocruz.br/pos/

    • United States
    • Biotechnology Research
    • 700 & Above Employee
    • Sênior Market Access Consultant
      • Jun 2021 - Sep 2021

    • Brazil
    • Hospitals and Health Care
    • 1 - 100 Employee
    • Market Access, Regulatory Affairs senior consultant
      • Apr 2017 - May 2021

      International Market Access Projects and value messages to rare diseases and oncologic products. Guidance to post-approval variations and renewals (drug products – Rx and OTC, biological products). Large knowledge in new products regulation, recalls, GMP inspections, controlled products, importation and exportation processes. International Market Access Projects and value messages to rare diseases and oncologic products. Guidance to post-approval variations and renewals (drug products – Rx and OTC, biological products). Large knowledge in new products regulation, recalls, GMP inspections, controlled products, importation and exportation processes.

  • Takeda Farmacêutica Brasil
    • São Paulo Area, Brazil
    • Strategic Market Access & Pricing Manager
      • Jun 2015 - Aug 2016

      Strategies to develop acess to products in the public and private market. Theses strategies are to Inflammatory bowel disease (IBD), Anemia and Oncology field. Since price register untill value messages to diferente stakeholders. Also in charge of price management to all company products. Strategies to develop acess to products in the public and private market. Theses strategies are to Inflammatory bowel disease (IBD), Anemia and Oncology field. Since price register untill value messages to diferente stakeholders. Also in charge of price management to all company products.

    • United States
    • Pharmaceutical Manufacturing
    • 700 & Above Employee
    • Market Access and Pricing Manager
      • Jul 2013 - Dec 2014

      Strategies to pre-launch of hepatitis C product, price management of all products in CMED, headquarter and prepare the price strategy to federal purchases. Strategies to pre-launch of hepatitis C product, price management of all products in CMED, headquarter and prepare the price strategy to federal purchases.

    • United States
    • Pharmaceutical Manufacturing
    • 700 & Above Employee
    • Market Access and Pricing Manager (Schering-Plough and MSD)
      • Jul 2008 - Jun 2013

      Strategies to products in the public market, as Boceprevir to Heptites C and HPV Vaccine, both in the federal program. To private market, oncologic products as Temodal, Bridion, Emend and Onicit Development pharmaeconomics studies to add value in the marketing strategy of several products, and leading international multifunctional groups. (Before Schering-Plough completed the acquisition of Organon BioSciences I was pointed as High-Performance Professional and invited to lead Market Access area at Schering-Plough, which sometime later was acquired by MSD)

    • United States
    • Pharmaceutical Manufacturing
    • 700 & Above Employee
    • Regulatory Affairs Manager
      • Jun 2006 - Jun 2008

      Developed the regulatory strategy to new business for contraceptive generic products and cosmetics, building a new team of 66% of internal approval. (the previous one used to be 38%). Developed the regulatory strategy to new business for contraceptive generic products and cosmetics, building a new team of 66% of internal approval. (the previous one used to be 38%).

    • Pharmaceutical Manufacturing
    • 700 & Above Employee
    • Regulatory Affairs Leader
      • 2004 - 2006

      In Brazil, the changes in the regulatory scenario drove the companies to receive huge penalties, so as the Manager of Regulatory Affairs, I developed a team to avoid further infractions and also I got a decrease of 60% in the penalties’ value. In Brazil, the changes in the regulatory scenario drove the companies to receive huge penalties, so as the Manager of Regulatory Affairs, I developed a team to avoid further infractions and also I got a decrease of 60% in the penalties’ value.

    • Pharmaceutical Manufacturing
    • 1 - 100 Employee
    • Regulatory Affairs Manager
      • Apr 2001 - Feb 2004

      Registration of the first generic product in Brazil and others 25 products more.Registration of a new molecule, the Retinaldehyde, for cosmetics usage in the country.

    • Regulatory Affairs Specialist
      • Aug 1997 - Apr 2001

      Executing registration plans and all change controls needs such as renewals, labelling updates.

Education

  • Universidade de São Paulo
    Farmacia Bioquímica, Pharmacy and Biochemistry
    1992 - 1997
  • Fundação Getúlio Vargas
    MBA, Law and Business
    2000 - 2002
  • Faculdade de Direito de São Bernardo do Campo
    Bacharel, Law
    2003 - 2008
  • FIA - Fundação Instituto de Administração
    Post Graduate, Finanças Corporativas & Investment Banking | Corporate Finance & Investment Banking
    2015 - 2016

Community

You need to have a working account to view this content. Click here to join now